Most CAD patients have comorbidities, such as arterial hypertension, dyslipidaemia, or diabetes mellitus, and were treated accordingly (antiplatelets, statin, β-blocker, angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, etc.). Here, ACE is linked to inherited lipid metabolism disorder.